Christoph Röllig

Trials

Studies that name Christoph Röllig as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:05 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT05904106 · Venetoclax Plus Azacitidine Versus Intensive Chemotherapy for Fit Patients With Newly Diagnosed NPM1 Mutated AML

  Technische Universität Dresden · recruiting · Acute Myeloid Leukemia · principal investigator
• Ph1/Ph2
  NCT04385290 · Combination of Midostaurin and Gemtuzumab Ozogamicin in First-line Standard Therapy for Acute Myeloid Leukemia (MOSAIC)

  Technische Universität Dresden · recruiting · Acute Myeloid Leukemia · principal investigator
• Ph1/Ph2
  NCT04330820 · Trial for Relapsed or Refractory AML Patients Combining Cytarabine and Mitoxantrone With Venetoclax (RELAX)

  Technische Universität Dresden · completed · Relapsed Adult AML, Refractory AML · principal investigator
• N/A
  NCT03188874 · Clinical AML Registry and Biomaterial Database of the Study Alliance Leukemia (SAL)

  Technische Universität Dresden · recruiting · Acute Myeloid Leukemia (AML) · study director
• Ph3
  NCT02140242 · Comparison Between Two Dose Levels of Daunorubicin and Between One vs. Two Induction Cycles for Adult Patients With AML

  Technische Universität Dresden · completed · Leukemia, Myelocytic, Acute · principal investigator
• Ph2
  NCT01830361 · Trial to Assess the Efficacy of Midostaurin (PKC412) in Patients With c-KIT or FLT3-ITD Mutated t(8;21) AML

  Technische Universität Dresden · completed · Acute Myeloid Leukemia · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 08:05 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.